Adolor Corporation to Present at 27th Annual J. P. Morgan Healthcare Conference
January 12 2009 - 4:00PM
Business Wire
Adolor Corporation (Nasdaq:ADLR) today announced that Michael R.
Dougherty, President and Chief Executive Officer, will present at
the 27th Annual J. P. Morgan Healthcare Conference on Thursday,
January 15, 2009 at Noon Pacific Time (3:00 P.M. Eastern Time). The
conference is being held at the Westin St. Francis Hotel in San
Francisco, California.
Adolor�s presentation will be webcast live for investors through
www.adolor.com and available for a period of 14 days following the
conference.
About Adolor Corporation
Adolor Corporation is a biopharmaceutical company specializing
in the discovery, development and commercialization of novel
prescription pain management products.
Adolor�s first approved product in the United States is
ENTEREG�, which is indicated to accelerate the time to upper and
lower gastrointestinal recovery following partial large or small
bowel resection surgery with primary anastomosis. ENTEREG is
available for short-term use in hospitals registered under the
ENTEREG Access Support and Education (E.A.S.E.TM) Program. In
collaboration with GlaxoSmithKline, the company launched ENTEREG in
mid-2008.
For more information, visit www.adolor.com.
This press release is available on the website
http://www.adolor.com.
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jul 2023 to Jul 2024